Skip to main content
OpenTrials
Completed

NCT Number: NCT00260416

Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours

Background: Acute balloon angioplasty is beneficial in patients with acute myocardial infarction. However, presently this treatment is not offered to patients with symptom duration above 12 hours.

Hypothesis: Acute balloon angioplasty for myocardial infarction is beneficial despite symptom duration above 12 hours.

Methods: In 60 patients with myocardial infarction and symptom duration above 12 hours, the proportion of non-perfused myocardium before acute angioplasty and 1 month after angioplasty is compared to evaluate if myocardial tissue can be saved by acute angioplasty despite long symptom duration.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Departments of Cardiology and Nuclear Medicine at Skejby Hospital

Aarhus, DK-8200 N, Denmark

About this study

Methods: On arrival at our angioplasty laboratory, patients are informed about the study. If they accept to participate, we infuse 600 MBq of Sestamibi i.v. This binds in a first passage fashion without later redistribution to perfused myocardium. Non-perfused myocardium does not bind sestamibi. Primary angioplasty with stent and abciximab is then performed followed by myocardial scintigraphy to illustrate the non-perfused myocardial area that was at risk of infarction before the coronary artery was opened. Echocardiography is also performed. At 1 month, myocardial scintigraphy is repeated to evaluate infarct size. The difference between the myocardial area at risk of infarction before angioplasty and the myocardial infarct size 1 month later is defined as "salvage". Scintigraphy is repeated at 6 month and echocardiography is also repeated at 1 month and 6 months. The primary endpoint is "salvage". Accordingly, the aim is to demonstrate that salvage can be achieved with primary angioplasty for acute myocardial infarction despite symptom duration above 12 hours. Clinical endpoints are death and reinfarction. The results are compared with results in 200 patients with symptom duration below 12 hours. These patients are treated and examined according to the exact same protocol. By this comparison, it can be evaluated whether it is relevant that the current guidelines recommend acute balloon angioplasty only to patients with less than 12 hours of symptom duration.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute myocardial infarction with ST-segment elevation;
  • Symptom duration 12 hours to 72 hours.

Exclusion criteria

  • Age below 18 years;
  • Bleeding disorders or anaemia or low levels of thrombocytes;
  • Thrombolysis used during the present admission;
  • Expected survival less than 1 year due to other diseases;
  • Previous acute myocardial infarction or coronary by-pass surgery;
  • Major operation within last 30 days;
  • Heamorrhaghic stroke within last 3 months.

Treatment and study plan

Primary angioplasty with stent and abciximab

Procedure

Primary outcomes

  1. Myocardial salvage as evaluated by repeat myocardial scintigraphy(= area at risk of infarction before primary angioplasty - infarct size at 1 month).

Secondary outcomes

  1. Infarct size by myocardial scintigraphy at 1 month and 6 months after primary angioplasty.

  2. Death at 1 month and 6 months.

  3. Reinfarction at 1 month and 6 months.

  4. Ejection fraction at 1 day, 1 month and 6 months.

  5. Left ventricular end diastolic volume at 1 day, 1 month and 6 months.

  6. Brain Natriuretic Peptide levels at 1 day, 1 month and 6 months.

Sponsors and collaborators

Lead sponsor

Aarhus University Hospital Skejby

Other

Collaborators

  • Danish Heart Foundation

Registry information

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Dec 1, 2005
Registry last updated
May 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.